TJ Biopharma Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 20

TJ Biopharma General Information

Description

Provider of biopharmaceutical development and manufacturing services intended for the treatment of autoimmune diseases and oncology. The company offers contract manufacturing, drug discovery, clinical trial management, regulatory facilitation, antibody conjugate development, and biopharmaceutical production, thereby e8731 8731 nabling biopharmaceutical companies to accelerate the development and commercialization of next-generation therapies.

Contact Information

Website
www.tjbio.com
Formerly Known As
I-Mab Biotechnology (Hangzhou)
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th Floor, Building 3, Hexiang Technology Center
  • Intersection of Fucheng Road and Yinhai Street
  • Hangzhou, Zhejiang 310018
  • China
+86 0571
Primary Industry
Drug Discovery
Vertical(s)
Manufacturing, Life Sciences, Oncology
Corporate Office
  • 6th Floor, Building 3, Hexiang Technology Center
  • Intersection of Fucheng Road and Yinhai Street
  • Hangzhou, Zhejiang 310018
  • China
+86 0571

TJ Biopharma Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TJ Biopharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Secondary Transaction - Private 04-Dec-2025 Completed Generating Revenue
6. Later Stage VC (Series C2) 28-Sep-2025 Completed Generating Revenue
5. Secondary Transaction - Private 12-May-2025 Completed Generating Revenue
4. Later Stage VC (Series C) 08-Feb-2024 Completed Generating Revenue
3. Secondary Transaction - Private 21-Sep-2023 Completed Generating Revenue
2. Secondary Transaction - Private 13-Sep-2022 Completed Generating Revenue
1. Secondary Transaction - Private 15-Oct-2020 Completed Generating Revenue
To view TJ Biopharma’s complete valuation and funding history, request access »

TJ Biopharma Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
CICC Capital PE/Buyout Minority
CICC Private Equity Corporate Venture Capital Minority
ENN Energy Holdings Corporation Minority
Hainan Zhenmai Private Equity Fund Management Partnership Growth/Expansion Minority
HSG (Hong Kong) Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Ready to get started?

Request a free trial

TJ Biopharma FAQs

  • When was TJ Biopharma founded?

    TJ Biopharma was founded in 2019.

  • Where is TJ Biopharma headquartered?

    TJ Biopharma is headquartered in Hangzhou, China.

  • What industry is TJ Biopharma in?

    TJ Biopharma’s primary industry is Drug Discovery.

  • Is TJ Biopharma a private or public company?

    TJ Biopharma is a Private company.

  • What is TJ Biopharma’s current revenue?

    The current revenue for TJ Biopharma is .

  • How much funding has TJ Biopharma raised over time?

    TJ Biopharma has raised $154M.

  • Who are TJ Biopharma’s investors?

    CICC Capital, CICC Private Equity, ENN Energy Holdings, Hainan Zhenmai Private Equity Fund Management Partnership, and HSG (Hong Kong) are 5 of 20 investors who have invested in TJ Biopharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process